Kit Check has raised $12 million in series B funding round, led by Kaiser Permanente Ventures and Rex Health Ventures as a minor investor. Also participating in this round were Series A investors, such as New Leaf Venture Partners, Sands Capital Ventures, Easton Capital Investment Group, Lionbird, and Rex Health Ventures.

The company, which is a leader in hospital pharmacy kit processing and medication tracking software, has achieved tremendous growth in the eighteen months since the 2013 funding round. At that time, Kit Check was serving seven hospitals with its cloud-software and RFID-based solution. By the end of 2013, the customer count had grown to 43, only to reach 144 in December 2014.

Kit Check introduced its second product in 2014, Anesthesia Check, which is currently in operating rooms at three leading hospital systems. This service tracks medications from vial dispensing in the pharmacy, to operating room syringe prep, to patient administration and waste – automating recording and safety checks throughout the medication lifecycle.

The company has raised $22.4 million to date, including the $10.4 million Series A Round closed in 2013.